Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06512441

Vitamin B6 Aids in Treating Inflammatory Bowel Disease

Vitamin B6 Assists in the Treatment of Inflammatory Bowel Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Patients with IBD are randomized to oral administration of VitaminB6 and placebo based on the standard treatment, exploring whether VitaminB6 can increasee the clinical remission rateand improve the treatment effect of IBD patients.

Detailed description

Inflammatory bowel disease (IBD) is a group of chronic idiopathic inflammatory intestinal diseases, mainly including ulcerative colitis and Crohn's disease, with increasing incidence in China and worldwide. The disease currently lacks a cure, with many patients experiencing relapses and requiring surgery, and an increased risk of cancer. There is substantial evidence suggesting a close relationship between body vitamin B6 levels and IBD.Thus,we design this clinical trial that aims to explore whether VitaminB6 can increasee the clinical remission rateand improve the treatment effect.

Conditions

Interventions

TypeNameDescription
DRUGVitamin B6 TabletsThe experimental group was given a Vitamin B6 tablet(10mg/tablet)once a day for 3weeks, besides of the standard IBD treatment.
DRUGPlaceboThe control group was given a placebo tablet on the same type once a day for 3weeks, besides of the standard IBD treatment.

Timeline

Start date
2024-06-01
Primary completion
2025-12-30
Completion
2025-12-30
First posted
2024-07-22
Last updated
2024-07-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06512441. Inclusion in this directory is not an endorsement.